Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 December, 2024
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 532843 | NSE: FORTIS

Fortis Healthcare Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 21, 2024, 2:34 am

Market Cap 51,175 Cr.
Current Price 678
High / Low 740/375
Stock P/E74.4
Book Value 104
Dividend Yield0.15 %
ROCE10.3 %
ROE7.85 %
Face Value 10.0
PEG Ratio1.20

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for

Competitors of

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
NG Industries Ltd 61.0 Cr. 182 230/13610.4 1241.92 %6.50 %5.63 % 10.0
Global Longlife Hospital and Research Ltd 32.0 Cr. 30.5 61.7/27.0 25.90.00 %2.51 %4.72 % 10.0
Gian Lifecare Ltd 19.6 Cr. 19.0 29.0/17.04.82 19.20.00 %29.2 %24.6 % 10.0
Fortis Malar Hospitals Ltd 111 Cr. 59.1 108/44.0 15.971.9 %3.29 %9.12 % 10.0
Family Care Hospitals Ltd 36.7 Cr. 6.79 10.3/6.230.89 2.670.00 %15.4 %24.1 % 10.0
Industry Average25,292.00 Cr771.7353.9289.623.18%12.34%12.42%9.12

All Competitor Stocks of

Quarterly Result

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales1,4101,4631,4671,3781,4881,6071,5601,6431,6571,7701,6801,7861,859
Expenses1,1351,1781,1801,1571,2371,3041,2831,3721,3861,4401,3961,4051,516
Operating Profit275284287221251303276271272330284381343
OPM %20%19%20%16%17%19%18%16%16%19%17%21%18%
Other Income322132013317526261018191714
Interest38403830313333323132333535
Depreciation73757677747783827984879291
Profit before tax486182193126176268186183171233183271230
Tax %11%28%27%31%24%19%24%25%27%21%27%25%24%
Net Profit43113114287134218142138124184134203174
EPS in Rs3.491.421.550.901.622.711.721.761.482.301.782.372.20

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales3,0423,4923,9664,1994,5744,5614,4694,6324,0305,7186,2986,8937,094
Expenses3,8273,4303,8574,1064,2204,2874,2384,0223,6264,6495,1965,6255,757
Operating Profit-78562109923542742316104041,0691,1011,2681,338
OPM %-26%2%3%2%8%6%5%13%10%19%17%18%19%
Other Income2,16915292299649-689228126953671576469
Interest461250152133229258337205166147129131135
Depreciation229183235225222239233292291301316342354
Profit before tax694-219-18534552-912-11023943988814858917
Tax %25%5%2%-24%13%2%103%62%230%20%22%25%
Net Profit528-218-13042479-934-22491-56790633645695
EPS in Rs12.34-4.73-3.100.408.14-19.46-3.960.77-1.457.357.807.938.65
Dividend Payout %0%-0%-1%0%0%0%0%0%0%0%13%13%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-141.29%40.37%132.31%1040.48%-294.99%76.02%140.62%-161.54%1510.71%-19.87%1.90%
Change in YoY Net Profit Growth (%)0.00%181.65%91.94%908.17%-1335.47%371.01%64.61%-302.16%1672.25%-1530.59%21.77%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:9%
3 Years:20%
TTM:10%
Compounded Profit Growth
10 Years:17%
5 Years:43%
3 Years:136%
TTM:30%
Stock Price CAGR
10 Years:21%
5 Years:39%
3 Years:35%
1 Year:74%
Return on Equity
10 Years:3%
5 Years:4%
3 Years:7%
Last Year:8%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 12:31 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital405463463463518519755755755755755755755
Reserves3,3013,8203,5853,9984,6263,5435,8465,9065,3655,4236,4876,9087,092
Borrowings7,1452,5501,7841,5132,2171,9622,0101,5941,5311,2559261,1551,186
Other Liabilities2,6621,0181,7601,2572,2272,4552,8752,7813,2164,0823,9214,1534,563
Total Liabilities13,5147,8517,5927,2329,5888,47911,48611,03610,86611,51612,08912,97113,597
Fixed Assets9,2744,1474,2183,6425,4194,9928,4778,8028,7999,4169,4269,87410,172
CWIP244147228226268226450204165193228542435
Investments1,1871,8171,4641,4521,8781,732270175186104210230175
Other Assets2,8081,7391,6821,9132,0231,5292,2901,8561,7161,8032,2252,3262,814
Total Assets13,5147,8517,5927,2329,5888,47911,48611,03610,86611,51612,08912,97113,597

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +1,64447924195966493-1791724858658221,100
Cash from Investing Activity +-1,4902,503213122-1,001-333-3,27963-131-501-372-889
Cash from Financing Activity +-74-3,217-304-354259-6724,257-862-143-517-471-86
Net Cash Flow80-235-66-37225-513799-627212-153-21125

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-792.0060.00108.0091.00352.00273.00229.00609.00403.000.00-925.000.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days804638393838443641333433
Inventory Days432625232324223029333124
Days Payable413200207218215279296226205178179164
Cash Conversion Cycle-290-128-144-156-155-217-230-161-135-112-115-107
Working Capital Days-133-16-69-24-33-76-133-116-37-21-12-115
ROCE %1%0%-0%3%11%3%6%4%2%10%10%10%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%
FIIs29.33%30.08%29.82%29.66%30.59%31.01%31.22%30.03%26.31%23.72%23.24%23.31%
DIIs15.79%15.67%16.90%17.60%20.02%20.38%20.69%22.17%26.55%29.42%31.14%32.31%
Public23.71%23.08%22.12%21.57%18.22%17.44%16.92%16.65%15.97%15.71%14.44%13.22%
No. of Shareholders1,66,7431,54,5721,56,8811,60,7621,58,4551,43,5191,37,8941,35,0471,31,5161,35,6641,57,1651,54,260

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Mid-Cap Opportunities Fund - Regular Plan21,353,3751.441015.039,491,5632024-12-20124.97%
Kotak Emerging Equity Fund - Regular Plan20,190,2781.96959.749,491,5632024-12-20112.72%
Axis Midcap Fund13,299,3712.1632.199,491,5632024-12-2040.12%
Nippon India Growth Fund13,200,0002.03627.469,491,5632024-12-2039.07%
HDFC Small Cap Fund - Regular Plan12,453,2751.88591.979,491,5632024-12-2031.2%
Mirae Asset Large & Midcap Fund9,491,5631.19451.189,491,5632024-12-200%
Aditya Birla Sun Life ELSS Tax Saver Fund8,360,1442.44397.49,491,5632024-12-20-11.92%
Mirae Asset Midcap Fund7,435,4612.12353.449,491,5632024-12-20-21.66%
SBI Long Term Equity Fund7,065,3041.3335.859,491,5632024-12-20-25.56%
Kotak Multicap Fund5,485,0431.97260.739,491,5632024-12-20-42.21%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)7.937.807.35-1.450.77
Diluted EPS (Rs.)7.937.807.35-1.450.77
Cash EPS (Rs.)12.9612.2814.132.484.91
Book Value[Excl.RevalReserv]/Share (Rs.)113.33107.3092.8388.9895.44
Book Value[Incl.RevalReserv]/Share (Rs.)113.33107.3092.8388.9895.44
Revenue From Operations / Share (Rs.)91.3083.4275.7353.3861.36
PBDIT / Share (Rs.)17.3015.4014.525.978.77
PBIT / Share (Rs.)12.7611.2210.542.124.91
PBT / Share (Rs.)11.2410.4912.76-0.053.01
Net Profit / Share (Rs.)8.428.1010.14-1.371.05
NP After MI And SOA / Share (Rs.)7.937.807.35-1.450.76
PBDIT Margin (%)18.9418.4619.1711.1914.29
PBIT Margin (%)13.9713.4513.913.987.99
PBT Margin (%)12.3012.5716.85-0.104.90
Net Profit Margin (%)9.229.7013.39-2.571.71
NP After MI And SOA Margin (%)8.689.349.70-2.721.25
Return on Networth / Equity (%)7.818.128.98-1.790.86
Return on Capital Employeed (%)9.527.697.491.614.22
Return On Assets (%)4.504.734.67-0.980.51
Long Term Debt / Equity (X)0.090.070.120.150.14
Total Debt / Equity (X)0.110.090.150.180.19
Asset Turnover Ratio (%)0.530.090.070.050.06
Current Ratio (X)0.440.980.890.840.36
Quick Ratio (X)0.410.900.790.770.33
Dividend Payout Ratio (NP) (%)12.600.000.000.000.00
Dividend Payout Ratio (CP) (%)8.010.000.000.000.00
Earning Retention Ratio (%)87.400.000.000.000.00
Cash Earning Retention Ratio (%)91.990.000.000.000.00
Interest Coverage Ratio (X)9.979.017.472.723.23
Interest Coverage Ratio (Post Tax) (X)5.735.164.070.361.09
Enterprise Value (Cr.)32853.8320823.6923306.9716352.4511111.40
EV / Net Operating Revenue (X)4.773.314.084.062.40
EV / EBITDA (X)25.1617.9021.2636.2616.78
MarketCap / Net Operating Revenue (X)4.603.123.833.732.05
Retention Ratios (%)87.390.000.000.000.00
Price / BV (X)4.142.713.552.451.43
Price / Net Operating Revenue (X)4.603.123.833.732.05
EarningsYield0.010.020.02-0.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of December 21, 2024 is: 608.31

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 21, 2024, is Overvalued by 10.28% compared to the current share price 678.00

Intrinsic Value of as of December 21, 2024 is: 984.44

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 21, 2024, is Undervalued by 45.20% compared to the current share price 678.00

Last 5 Year EPS CAGR: 61.83%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -65.42, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -162.50, which is a positive sign.
  3. The company has higher reserves (5,069.23 cr) compared to borrowings (2,063.69 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (4.38 cr) and profit (285.62 cr) over the years.
  1. The stock has a low average ROCE of 5.00%, which may not be favorable.
  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
    1. Net Profit Margin: 9.22%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 9.52% (Industry Average ROCE: 12.34%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 7.81% (Industry Average ROE: 12.42%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 5.73
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.41
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 74.4 (Industry average Stock P/E: 53.92)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.11
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Fortis Healthcare Ltd. is a Public Limited Listed company incorporated on 28/02/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L85110PB1996PLC045933 and registration number is 045933. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 862.61 Cr. and Equity Capital is Rs. 754.96 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesFortis Hospital, Mohali Punjab 160062secretarial@fortishealthcare.com
http://www.fortishealthcare.com
Management
NamePosition Held
Mr. Ravi RajagopalChairperson & Independent Director
Dr. Ashutosh RaghuvanshiManaging Director & CEO
Ms. Suvalaxmi ChakrabortyIndependent Director
Mr. Indrajit BanerjeeIndependent Director
Ms. Shailaja ChandraIndependent Director
Mr. Tomo NagahiroNon Executive Director
Mr. Dilip KadambiNon Executive Director
Mr. Lim Tsin LinNon Executive Director
Mr. Mehmet Ali AydinlarNon Executive Director
Dr. Prem Kumar NairNon Executive Director
Mr. Ashok PanditNon Executive Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 21 December 2024 is ₹608.31, which is 10.28% lower than the current market price of ₹678.00. The stock has a market capitalization of 51,175 Cr. and recorded a high/low of 740/375 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹7,092 Cr and total liabilities of ₹13,597 Cr.

What is the Market Cap of ?

The Market Cap of is 51,175 Cr..

What is the current Stock Price of as on 21 December 2024?

The current stock price of as on 21 December 2024 is 678.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 740/375.

What is the Stock P/E of ?

The Stock P/E of is 74.4.

What is the Book Value of ?

The Book Value of is 104.

What is the Dividend Yield of ?

The Dividend Yield of is 0.15 %.

What is the ROCE of ?

The ROCE of is 10.3 %.

What is the ROE of ?

The ROE of is 7.85 %.

What is the Face Value of ?

The Face Value of is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in . Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE